Belfast · Northern Ireland
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works

China's National Medical Products Administration approves the use of the neutralizing antibody cocktail developed by BRII Biosciences to treat COVID-19 in adults and teenagers

China's National Medical Products Administration approves the use of the neutralizing antibody cocktail developed by BRII Biosciences to treat COVID-19 in adults and teenagers.

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthChina's National Medical Products Administration approves the use of the neutralizing antibody cocktail developed by BRII Biosciences to treat COVID-19 in adults and teenagers

China's National Medical Products Administration approves the use of the neutralizing antibody cocktail developed by BRII Biosciences to treat COVID-19 in adults and teenagers.

View Premium plansBrowse free archive reports